Nearly a third of children diagnosed with celiac disease also have another autoimmune condition — and among that group, celiac is far more likely to be completely silent. A five-year study published in Frontiers in Pediatrics found that children with conditions like type 1 diabetes or autoimmune thyroid disease were dramatically more likely to have no digestive symptoms when celiac was discovered.
The implication is direct: waiting for symptoms before testing high-risk children will miss cases. Periodic, structured screening is the only reliable way to find celiac in this population.
What This Means for You
Researchers at a children’s hospital in north-eastern Romania followed 58 pediatric celiac patients between 2020 and 2024. Eighteen of them — 31% — had at least one other autoimmune condition alongside celiac, most commonly type 1 diabetes and autoimmune thyroiditis (an immune-driven thyroid disorder also known as Hashimoto’s disease).
The numbers tell a striking story. Among children without another autoimmune condition, just 2.5% had no symptoms at the time of their celiac diagnosis. Among children with a coexisting condition, that figure jumped to 27.8% — more than one in four. Those high-risk children also tended to receive their celiac diagnosis at an older age, which suggests their celiac went undetected longer because nothing obvious prompted a workup.
For celiac families — especially those already managing type 1 diabetes or thyroid disease — this matters directly. No gut symptoms is not a reliable sign that celiac isn’t there. It may simply mean no one has tested for it yet.
As a celiac parent, I’ve come to understand that the burden of tracking what to test, when, and why falls on families more often than on any single specialist. Research like this gives families the evidence they need to advocate with their child’s care team.
Key Takeaways
- Children with type 1 diabetes or autoimmune thyroid disease are far more likely to have celiac without any digestive symptoms
- In this study, more than 1 in 4 children with a coexisting autoimmune condition were asymptomatic when celiac was found — compared to just 1 in 40 without those conditions
- Celiac was diagnosed at an older age in the high-risk group, suggesting later detection when only symptoms trigger testing
- Girls were significantly overrepresented among children with coexisting autoimmune conditions
- Periodic celiac antibody testing — not waiting for complaints — is the only dependable approach for children at elevated autoimmune risk
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.
Why Autoimmune Conditions Cluster Together
Immune-mediated conditions are diseases caused by the immune system attacking the body’s own tissues. Celiac disease fits this category: when genetically susceptible people eat gluten, the immune system damages the lining of the small intestine. Type 1 diabetes mellitus (T1DM) is another — the immune system destroys insulin-producing cells in the pancreas. Autoimmune thyroiditis, also called Hashimoto’s disease, involves immune attack on the thyroid gland.
These conditions cluster because they share overlapping genetic risk factors and immune pathways. Having one raises the likelihood of developing another. That shared biology is why celiac guidelines already recommend routine monitoring for children with T1DM or thyroid disease — but as this study shows, that monitoring doesn’t always happen consistently in everyday clinical practice.
The 2020 ESPGHAN Criteria
The study used the 2020 ESPGHAN criteria — diagnostic standards for pediatric celiac disease from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. A meaningful update in those guidelines was allowing non-biopsy diagnosis in selected cases: children with very high levels of a specific antibody (anti-tissue transglutaminase IgA, or anti-tTG-IgA) can be confirmed as having celiac without an intestinal biopsy, provided other criteria are met. This makes celiac detection less invasive and more practical — relevant for children who are being monitored for other autoimmune conditions and aren’t presenting with obvious complaints.
Asymptomatic Presentation and What It Means Clinically
The study’s sharpest contrast was in how celiac appeared at diagnosis. Children without coexisting conditions were overwhelmingly symptomatic, typically presenting with a mix of gastrointestinal complaints (bloating, diarrhea, abdominal pain) and extraintestinal signs (fatigue, anemia, poor growth). Among children with coexisting immune-mediated conditions, more than a quarter had no symptoms at all — celiac was found only because someone thought to test for it.
Children in the high-risk group were also diagnosed at a statistically older age (p = 0.020). That result is not random variation. It reflects a systematic pattern: children who don’t show classic symptoms are caught later, and only when targeted surveillance is in place to catch them.
The researchers frame this as clinical heterogeneity — the variation in how a disease presents across different patients. The presence of another autoimmune condition appears to shift celiac away from the visible, identifiable symptoms that typically trigger investigation. Recognizing that shift is what allows clinicians and families to respond before damage accumulates.
The Case for Targeted Surveillance
The paper’s conclusion calls for “targeted surveillance and screening strategies in children at increased autoimmune risk.” Clinically, this means periodic blood tests — specifically anti-tTG-IgA antibody levels — for children who have T1DM or thyroid disease, regardless of digestive complaints. Major pediatric gastroenterology guidelines already endorse this. The contribution of this study is empirical evidence from routine clinical care showing how stark the difference really is when screening is or isn’t performed.
This connects to territory we’ve examined before. Our earlier piece on the challenge of diagnosing celiac in pediatric type 1 diabetes found that long-term serological surveillance — repeated antibody testing over time — is essential for reliable detection in children with T1DM. This Romanian cohort adds supporting evidence from a different region and a broader autoimmune population, reinforcing the same core message.
The study also found that female sex was significantly more prevalent among children with coexisting immune-mediated conditions, mirroring well-established patterns of autoimmune disease being more common in girls and women. That’s another factor care teams may want to weigh when prioritizing who gets monitored most consistently.
One honest limitation: this is single-center data from one hospital in Romania, so the specific percentages shouldn’t be over-generalized. But the clinical pattern — asymptomatic celiac clustering in children with other autoimmune conditions — is consistent with findings from larger studies elsewhere. The value here is real-world confirmation in routine clinical practice, not just a controlled research environment. The pattern is real, and it matters.
Related Coverage
- Challenge of diagnosing celiac disease in pediatric type 1 diabetes mellitus: lessons from long-term serological surveillance
- Sub-Phenotyping of Pediatric Celiac Disease with Topological Data Analysis
- Psychosocial Impact of Celiac Disease on Primary Caregivers of Children in Jordan: A Cross-Sectional Study
References
- Boca LO, Ghiga G, Păduraru G, et al. Pediatric celiac disease and coexisting immune-mediated conditions: a five-year single-center study from North-Eastern Romania. Frontiers in Pediatrics. 2026;14:1786392. doi:10.3389/fped.2026.1786392. PubMed